Award
Delivery Order #SPE2DR26F2B33
Delivery Order for Ondansetron HCL by AmerisourceBergen under Pharmaceutical Supply IDV
Buyer
Defense Logistics Agency
Award Amount
$10.07
Ceiling
$10.07
Awarded
February 11, 2026
Period of Performance
Feb 11, 2026 – Feb 12, 2026
Identifier
SPE2DR26F2B33
NAICS
424210
This award represents a delivery order contract issued under an existing indefinite delivery vehicle (IDV) held by AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company. The order procures Ondansetron HCL 4 MG/2 ML vials, a medication commonly used to prevent nausea and vomiting, supporting healthcare treatment capabilities. This contract is significant for maintaining the continuity and reliability of pharmaceutical supplies critical to public health. The scope covers the delivery of specified pharmaceutical products within a brief, clearly defined period, ensuring timely fulfillment of the agency’s immediate medical supply needs. The initial IDV contract was competitively awarded, reflecting a strategic partnership to meet expansive government pharmaceutical demands over many years. The delivery order was carried out on a sole-source basis as part of the pre-established IDV agreement, streamlining procurement and logistical efficiency. Performance occurred at the company’s facility in Conshohocken, Pennsylvania, emphasizing regional supply chain support.
Description
4570809020!ONDANSETRON HCL 4 MG/2 ML VIAL 2ML